Literature DB >> 29140541

Regulatory T-cells in acute dengue viral infection.

Hemadri Eresha Jayaratne1, Dulharie Wijeratne1, Samitha Fernando1, Achala Kamaladasa1, Laksiri Gomes1, Ananda Wijewickrama2, Graham Stuart Ogg3, Gathsaurie Neelika Malavige1,3.   

Abstract

Although regulatory T-cells (Tregs ) have been shown to be expanded in acute dengue, their role in pathogenesis and their relationship to clinical disease severity and extent of viraemia have not been fully evaluated. The frequency of Tregs was assessed in 56 adult patients with acute dengue by determining the proportion of forkhead box protein 3 (FoxP3) expressing CD4+  CD25+ T-cells (FoxP3+ cells). Dengue virus (DENV) viral loads were measured by quantitative real-time polymerase chain reaction (PCR) and DENV-specific T-cell responses were measured by ex-vivo interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) assays to overlapping peptide pools of DENV-NS3, NS1 and NS5. CD45RA and CCR4 were used to phenotype different subsets of T-cells and their suppressive potential was assessed by their expression of cytotoxic T lymphocyte-antigen 4 (CTLA-4) and Fas. While the frequency of FoxP3+  cells in patients was significantly higher (P < 0·0001) when compared to healthy individuals, they did not show any relationship with clinical disease severity or the degree of viraemia. The frequency of FoxP3+  cells did not correlate with either ex-vivo IFN-γ DENV-NS3-, NS5- or NS1-specific T-cell responses. FoxP3+  cells of patients with acute dengue were predominantly CD45RA+ FoxP3low , followed by CD45RA-FoxP3low , with only a small proportion of FoxP3+  cells being of the highly suppressive effector Treg subtype. Expression of CCR4 was also low in the majority of T-cells, with only CCR4 only being expressed at high levels in the effector Treg population. Therefore, although FoxP3+  cells are expanded in acute dengue, they predominantly consist of naive Tregs , with poor suppressive capacity.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  FoxP3; T-cells; dengue; effector T-cells; regulatory T-cells

Mesh:

Substances:

Year:  2017        PMID: 29140541      PMCID: PMC5904698          DOI: 10.1111/imm.12863

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells.

Authors:  Xuguang Tai; François Van Laethem; Leonid Pobezinsky; Terry Guinter; Susan O Sharrow; Anthony Adams; Larry Granger; Michael Kruhlak; Tullia Lindsten; Craig B Thompson; Lionel Feigenbaum; Alfred Singer
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

2.  Altered profile of regulatory T cells and associated cytokines in mild and moderate dengue.

Authors:  H Tillu; A S Tripathy; P V Reshmi; D Cecilia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

3.  Evaluation of a commercial capture enzyme-linked immunosorbent assay for detection of immunoglobulin M and G antibodies produced during dengue infection.

Authors:  C T Sang; A J Cuzzubbo; P L Devine
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

4.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

5.  Dengue vaccine: WHO position paper – July 2016.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2016-07-29

6.  Virus-specific T lymphocytes home to the skin during natural dengue infection.

Authors:  Laura Rivino; Emmanuelle A Kumaran; Tun-Linn Thein; Chien Tei Too; Victor Chih Hao Gan; Brendon J Hanson; Annelies Wilder-Smith; Antonio Bertoletti; Nicholas R J Gascoigne; David Chien Lye; Yee Sin Leo; Arne N Akbar; David M Kemeny; Paul A MacAry
Journal:  Sci Transl Med       Date:  2015-03-11       Impact factor: 17.956

7.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

8.  T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?

Authors:  Juthathip Mongkolsapaya; Thaneeya Duangchinda; Wanwisa Dejnirattisai; Sirijit Vasanawathana; Panisadee Avirutnan; Aroonroong Jairungsri; Nuanpan Khemnu; Nattaya Tangthawornchaikul; Pojchong Chotiyarnwong; Kanokwan Sae-Jang; Michael Koch; Yvonne Jones; Andrew McMichael; Xiaoning Xu; Prida Malasit; Gavin Screaton
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

9.  Immunodominant T-cell responses to dengue virus NS3 are associated with DHF.

Authors:  Thaneeya Duangchinda; Wanwisa Dejnirattisai; Sirijit Vasanawathana; Wannee Limpitikul; Nattaya Tangthawornchaikul; Prida Malasit; Juthathip Mongkolsapaya; Gavin Screaton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

10.  Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection.

Authors:  Kerstin Lühn; Cameron P Simmons; Edward Moran; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Nguyen Than Ha Quyen; Le Thi Thu Thao; Tran Van Ngoc; Nguyen Minh Dung; Bridget Wills; Jeremy Farrar; Andrew J McMichael; Tao Dong; Sarah Rowland-Jones
Journal:  J Exp Med       Date:  2007-04-23       Impact factor: 14.307

View more
  6 in total

Review 1.  Human T Cell Response to Dengue Virus Infection.

Authors:  Yuan Tian; Alba Grifoni; Alessandro Sette; Daniela Weiskopf
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

2.  Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.

Authors:  Catherine J Reynolds; Patricia Watber; Camilla Natália Oliveira Santos; Danielle Rodrigues Ribeiro; Juliana Cardoso Alves; Adriana B L Fonseca; Ana J B Bispo; Roseane L S Porto; Kalliopi Bokea; Amélia Maria Ribeiro de Jesus; Roque Pacheco de Almeida; Rosemary J Boyton; Daniel M Altmann
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

Review 3.  Emerging patterns of regulatory T cell function in tuberculosis.

Authors:  A Ahmed; A Vyakarnam
Journal:  Clin Exp Immunol       Date:  2020-09-06       Impact factor: 4.330

Review 4.  Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections.

Authors:  Maheshi Mapalagamage; Daniela Weiskopf; Alessandro Sette; Aruna Dharshan De Silva
Journal:  Viruses       Date:  2022-01-25       Impact factor: 5.048

Review 5.  Host immune response against DENV and ZIKV infections.

Authors:  Shamala Devi Sekaran; Amni Adilah Ismail; Gaythri Thergarajan; Samudi Chandramathi; S K Hanan Rahman; Ravishankar Ram Mani; Felicita Fedelis Jusof; Yvonne A L Lim; Rishya Manikam
Journal:  Front Cell Infect Microbiol       Date:  2022-09-08       Impact factor: 6.073

6.  Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.

Authors:  Emily N Gallichotte; Thomas J Baric; Boyd L Yount; Douglas G Widman; Anna Durbin; Steve Whitehead; Ralph S Baric; Aravinda M de Silva
Journal:  PLoS Pathog       Date:  2018-02-26       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.